Modified amino acid-based molecules: Accumulation and health implications

Amino Acids in Human Nutrition and Health

Volumn , Issue , 2011, Pages 382-405

  Bengmark, S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872874839     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (194)

1. Abe, R. and Yamagishi, S. (2008) AGE-RAGE system and carcinogenesis. Current Pharmaceutical Design 14, 940-945.
2. Agalou, S., Ahmed, N. Babaei-Jadidi, R., et al. (2005) Profound mishandling of protein glycation degradation products in uremia and dialysis. Journal of the American Society of Nephrology 16, 1471-1485.
3. Ahmed, N., Lüthen, R., Häussinger, D., et al. (2005) Increased protein glycation in cirrhosis and therapeutic strategies to prevent it. Annals of the New York Academy of Sciences 1043, 718-724.
4. Ahrné, S., Nobaek, S., Jeppsson, B., et al. (1998) The normal Lactobacillus flora of healthy human rectal and oral mucosa. Journal of Applied Microbiology 85, 88-94.
5. Allen, T.J. and Jandeleit-Dahm, K.A. (2005) Preventing atherosclerosis with angiotensin-converting enzyme inhibitors: emphasis on diabetic atherosclerosis. Current Drug Targets-Cardiovascular & Hematological Disorders 5, 503-512.
6. Alverdy. J.C., Laughlin, R.S. and Wu, L. (2003) Influence of the critically ill state on host-pathogen interactions within the intestine: gut-derived sepsis redefined. Critical Care Medicine 31, 598-607.
7. American Cancer Society (2006) Choices for good health: American Cancer Society guidelines for nutrition and physical activity for cancer prevention. CA-A Cancer Journal for Clinicians 56, 310-312.
8. Aronsen, D. (2003) Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. Journal of Hypertension 21, 3-12.
9. Artaud-Wild, S.M., Connor, S.L., Sexton, G. and Connor, W.E. (1993) Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox. Circulation 88, 2771-2779.
10. Baptista, J.A.B. and Carvalho, R.C.B. (2004) Indirect determination of Amadori compounds in milk-based products by HPLC/ELSD/UV as an index of protein detorioration. Food Research International 37, 739-747.
11. Barile, G.R. and Schmidt, A.M. (2007) RAGE and its ligands in retinal disease. Current Molecular Medicine 7, 758-765.
12. Barnard, N.D., Cohen, J., Jenkins, D.J., et al. (2009) A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial. American Journal of Clinical Nutrition 89, 1588S-1596S.
13. Bengmark, S. (2006) Curcumin: an atoxic antioxidant and natural NF-kB, COX-2, LOX and iNOS inhibitor- a shield against acute and chronic diseases. Journal of Parenteral and Enteral Nutrition 30, 45-51.
14. Bierhaus, A., Schiekofer, S., Schwaninger, M., et al. (2001) Diabetes-associated sustained activation of the transcription factor nuclear factor-kB. Diabetes 50, 2792-2808.
15. Bierhaus, A., Humpert, P.M., Stern, D.M., et al. (2005a) Advanced glycation end product receptor-mediated cellular dysfunction. Annals of the New York Academy of Sciences 1043, 676-680.
16. Bierhaus, A., Humpert, P.M., Morcos, M., et al. (2005b) Understanding RAGE, the receptor for advanced glycation end products. Journal of Molecular Medicine 83, 876-886.
17. Bierhaus, A., Humpert, P.M. and Nawroth, P.P. (2006) Linking stress to inflammation. Anesthesiology Clinics 24, 325-340.
18. Birlouez-Aragon, I. and Tessier, F.J. (2003) Antioxidant vitamins and degenerative pathologies. A review of vitamin C. Journal of Nutrition, Health & Aging 7, 103-109.
19. Birlouez-Aragon, I., Saavedra, G., Tessier, F.J., Galinier, A., Ait-Ameur, L., Lacoste, F., Niamba, C.N., et al. (2010) A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. American Journal of Clinical Nutrition 91, 1220-1226.
20. Bohlender, J.M. Franke, S., Stein, G. and Wolf, G. (2005) Advanced glycation end products and the kidney. American Journal of Physiology-Renal Physiology 289, F645-659.
21. Boratynski, J. and Gorski. A. (2002) BSE: a consequence of cattle feeding with glycated molecules hostunknown? Medical Hypotheses 58, 276-278.
22. Brady, J. and Hoggan, R. (2002) Dangerous grains. Avery-Penguin Putnam, New York.
23. Brandtzaeg, P., Halstensen, T.S., Kett, K., et al. (1989) Immunobiology and immunopathology of human gut mucosa: Humoral immunity and intraepithelial lymphocytes. Gastroenterology 97, 1562-1584.
24. Burns, M., Gaynor, K. and Olm, V. (2003) Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo. Journal of Neuroscience 23, 5645-5649.
25. Carroll, K.K. (1975) Experimental evidence of dietary factors and hormone-dependent cancers. Cancer Research 35, 3374-3383.
26. Castellani, R., Smith, M.A., Richey, P.J. and Perry, G. (1996) Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Research 737, 195-200.
27. Ceriello, A. (2009) Hypothesis: the "metabolic memory", the new challenge of diabetes. Diabetes Research and Clinical Practice 86, S2-S6.
28. Chida, Y., Sudo, N. and Kubo, C. (2006) Does stress exacerbate liver diseases? Journal of Gastroenterology & Hepatology 21, 202-208.
29. Choi, Y.G., Kim, J.I., Jeon, Y.C., et al. (2004) Nonenzymatic glycation at the N terminus of pathogenic prion protein in transmissible spongiform encephalopathies. Journal of Biological Chemistry 279, 30402-30409.
30. Chou, S.M., Wang, H.S., Taniguchi, A. and Bacula, R. (1998) Advanced glycation end products in neurafilament conglomeration of motorneurons in familial and sporadic amyotrophic lateral sclerosis. Molecular Medicine 4, 324-332.
31. Chung, S.Y. and Champagne, E.T. (2001) Association of end-product adducts with increased IgE binding of roasted peanuts. Journal of Agricultural and Food Chemistry 49, 3911-3916.
32. Conway, B., Edmundowicz, D., Matter, N., et al. (2010) Skin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes. Diabetes Technology & Therapeutics 12, 339-345.
33. Cooper, E.V. (1946) Gas gangrene following injection of adrenaline. Lancet 247, 459-461.
34. Dahl-Jorgensen, K., Joner, G. and Hanssen, K.F. (1991) Relationship between cows' milk consumption and incidence of IDDM in childhood. Diabetes Care 14, 1081-1083.
35. Dalfo, E., Portero-Otin, M., Ayala, V., et al. (2005) Evidence of oxidative stress in the neocortex in incidental Lewy body disease. Journal of Neuropathology & Experimental Neurology 64, 816-830.
36. Daroux, M., Prévost, G., Maillard-Lefebvre, H., et al. (2010) Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies. Diabetes & Metabolism 36, 1-10.
37. Davis, P.J., Smales, C.M. and James, D.C. (2001) How can thermal processing modify the antigenicity of proteins? Allergy 56, 56-60.
38. DCCT (Diabetes Control and Complications Trial) (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 329, 977-986.
39. DeGroot, J. (2004) The AGE of the matrix: chemistry, consequence and cure. Current Opinion in Pharmacology 4, 301-305.
40. De Leeuw, K., Kallenberg, C. and Bijl, M. (2005) Accelerated atherosclerosis in patients with systemic autoimmune diseases. Annals of the New York Academy of Sciences 1051, 362-371.
41. Delmas, D., Jannin, B. and Latruffe, N. (2005) Resveratrol: preventing properties against vascular alterations and ageing. Molecular Nutrition & Food Research 49, 377-395.
42. Diamanti-Kandarakis, E., Piperi, C., Kalofoutis, A. and Creatsas, G. (2005) Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Clinical Endocrinology 62, 37-43.
43. di Cagno, R., de Angelis, M., Alfonsi, G., et al. (2005) Pasta made from durum wheat semolina fermented with selected lactobacilli as a tool for a potential decrease of the gluten intolerance. Journal of Agricultural and Food Chemistry 53, 4393-4402.
44. Dougan, M. and Dranoff, G.(2008) Inciting inflammation: the RAGE about tumor promotion. Journal of Experimental Medicine 205, 267-270.
45. Ekong, U., Zeng, S., Dun, H., et al. (2006) Blockade of the receptor for advanced glycation end products attenuates acetaminophen-induced hepatotoxicity in mice. Journal of Gastroenterology & Hepatology 21, 682-688.
46. Erbersdobler, H., Gunsser, I. and Weber, G. (1970) Abbau von Fructoselysine durch die Darmflora. Zentralblatt für Veterinärmedizin A17, 573-575.
47. Faist, V. and Erbersdobler, H.F. (2001). Metabolic transit and in vivo effects of melanoidins and precursor compounds deriving from the Maillard reaction. Annals of Nutrition and Metabolism 45, 1-12.
48. Faist, V., Wenzel, E. and Erbersdobler, H.F. (2000) In vitro and in vivo studies on the metabolic transit of Ne-carboxymethyllysine. Czech Journal of Food Sciences 18, 116-119.
49. Ferretti, G., Bacchetti, T. and Negre-Salvayre, A. (2006) Structural modifications of HDL and functional consequences. Atherosclerosis 184, 1-7.
50. Finegold, S.M., Sutter, V.L. and Mathisen, G.E. (1983) Normal indigenous intestinal flora. In: Hentges, D.J. (ed.) Human Intestinal Microflora in Health and Disease. Academic Press, London, pp. 3-31.
51. Finot, P.A. and Magnenat, E. (1981) Metabolic transit of early and advanced Maillard products. Progress in Food & Nutrition Science 5, 193-207.
52. Flyvbjerg, A., Khatir, D.S., Jensen. L.J., et al. (2004) The involvement of growth hormone (GH), insulin-like growth factors (IGFs) and vascular endothelial growth factor (VEGF) in diabetic kidney disease. Current Pharmaceutical Design 10, 3385-3394.
53. Foell, D., Seeliger, S., Vogl, T., et al. (2003) Expression of S100A12 (EN-RAGE) in cystic fibrosis. Thorax 58, 613-617.
54. Franck, P., Moneret Vautrin, D.A., Dousset, B., et al. (2002) The allergenicity of soybean-based products is modified by food technologies. International Archives of Allergy and Applied Immunology 128, 212-219.
55. Frey, J. (2002) Bovine spongiform encephalopathy: are the cows mad or full of carbohydrate. Clinical Chemistry and Laboratory Medicine 40, 101-103.
56. Gaby, A.R. (2005) Adverse effects of dietary fructose. Alternative Medicine Review 10, 294-306.
57. Ganmaa, D., Li, X.M. and Wang, J. (2002) Incidence and mortality of testicular and prostatic cancers in relation to world dietary practices. International Journal of Cancer 98, 262-267.
58. Ganmaa, D., Li, X.M., Qin, L.Q., et al. (2003) The experience of Japan as a clue to the etiology of testicular and prostatic cancers. Medical Hypotheses 60, 724-730.
59. Gawlowski, T., Stratmann, B. and Ruetter, R. (2009) Advanced glycation end products strongly activate platelets. European Journal of Nutrition 48, 475-481.
60. Ge, J., Jia, Q., Liang, C., et al. (2005) Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells. Arteriosclerosis, Thrombosis, and Vascular Biology 25, 2157-2163.
61. Gebhardt, C., Riehl, A., Durchdewald, M., Németh, J., Fürstenberger, G., Müller-Decker, K., Enk, A., et al. (2008) RAGE signaling sustains inflammation and promote tumor development. Journal of Experimental Medicine 205, 275-285.
62. Genkinger, J.M., Hunter, D.J., Spiegelman, D., et al. (2006) Dairy products and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiology, Biomarkers & Prevention 15, 364-372.
63. Genuth, S., Sun, W., Cleary, P., et al. (2005) Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes 54, 3103-3111.
64. Goldberg, T., Cai, W., Peppa, M., et al. (2004) Advanced glycoxidation end products in commonly consumed foods. Journal of the American Dietetic Association 104, 1287-1291.
65. Gomes, R., Sousa Silva, M., Quintas, A., et al. (2005) Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy. Biochemical Journal 385, 339-345.
66. Gugliucci, A., Kotani, K., Taing, J., et al. (2009), Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults. Annals of Nutrition and Metabolism 54, 197-201.
67. Hein, G. and Franke, S. (2002) Are advanced glycation end-product-modified proteins of pathogenetic importance in fibromyalgia? Rheumatology 41, 1163-1167.
68. Hein, G., Wiegand, R., Lehmann, G., et al. (2003) Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis. Rheumatology 42, 1242-1246.
69. Hein, G.E., Kohler, M., Oelzner, P., et al. (2005) The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis. Rheumatology International 26, 137-141.
70. Hertoghe, T. (2005). The "multiple hormone deficiency" theory of aging: is human senescence caused mainly by multiple hormone deficiencies? Annals of the New York Academy of Sciences 1057, 448-465.
71. Holla, L.I., Kankova, K., Fassmann, A., et al. (2001) Distribution of the receptor for advanced glycation end products gene polymorphisms in patients with chronic periodontitis: a preliminary study. Journal of Periodontology 72, 1742-1746.
72. Hormel, S.E. and Eyre, D.R. (1991) Collagen in the ageing human intervertebral disc: an increase in covalently bound fluorophores and chromophores. Biochimica et Biophysica Acta 1078, 243-250.
73. Hostettler-Allen, R.L., Tappy, L. and Blum, J.W. (1994) Insulin resistance, hyperglycemia, and glucosuria in intensively milk-fed calves. Journal of Animal Science 72, 160-173.
74. Hu, F.B., Manson, J.E., Stampfer, M.J., et al. (2001) Diet, lifestyle and the risk of type 2 diabetes mellitus in women. New England Journal of Medicine 345, 790-797.
75. Hyogo, H., Yamagishi, S., Iwamoto, K., et al. (2007) Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis. Journal of Gastroenterology & Hepatology 22, 1112-1119.
76. Iwashige, K., Kouda, K., Kouda, M., et al. (2004) Calorie restricted diet and urinary pentosidine in patients with rheumatoid arthritis. Journal of Physiological Anthropology and Applied Human Science 23, 19-24.
77. Jing, R., Cui, M., Wang, J. and Wang, H. (2010) Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer. Neoplasma 57, 55-61.
78. Kalousova, M., Zak, A. and Soukupova, J. (2005) Advanced glycation and oxidation products in patients with atherosclerosis. Cas Lek Cesk 144, 385-390 [in Czech].
79. Kato, S., Itoh, K., Ochiai. M., et al. (2008) Increased pentosidine, an advanced glycation end-product, in urine and tissue reflects disease activity in inflammatory bowel diseases. Journal of Gastroenterology & Hepatology 2, S140-S145.
80. Katz, J., Bhattacharyya, I., Farkhondeh-Kish, F., et al. (2005) Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing immunohistochemistry and RT-PCR. Journal of Clinical Periodontology 32, 40-44.
81. Kaufmann, E., Boehm, B.O. and Sussmuth, S.D. (2004) The advanced glycation end-product N epsilon- (carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Neuroscience Letters 371, 226-229.
82. Kaya, C., Erkan, A.F., Cengiz, S.D., et al. (2009) Advanced oxidation protein products are increased in women with polycystic ovary syndrome: relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndrome. Fertility and Sterility 92, 1372-1377.
83. Kikuchi, S., Shinpo, K., Ogata, A., et al. (2002) Detection of N-(carboxymethyl)lysine (CML) and non-CML advanced glycation end products in the anterior horn of amyotrophic lateral sclerosis spinal cord. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 3, 63-68.
84. Kinney, K.S., Austin, C.E., Morton, D.S. and Sonnenfeld, G. (2000) Norepinephrine as a growth stimulating factor in bacteria-mechanistic studies. Life Science 67, 3075-3085.
85. Kjaer, M. (2004) Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiological Reviews 84, 649-698.
86. Koyama, H., Shoji, T., Yokoyama, H., et al. (2005) Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 25, 2587-2593.
87. Krechler, T., Jáchymová, M. and Mestek, O. (2010) Soluble receptor for advanced glycation end-products (RAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer. Clinical Biochemistry 43, 10-11.
88. Kurien, B.T., Hensley, K., Bachmann, M. and Scofield, R.H. (2006) Oxidatively modified autoantigens in autoimmune diseases. Free Radical Biology & Medicine 41, 549-556.
89. Lalla, E., Lamster, I.B., Stern, D.M. and Schmidt, A.M. (2001) Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities. Annals of Periodontology 6, 113-118.
90. Larsson, S.C., Bergkvist, L. and Wolk, A. (2004) Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort. American Journal of Clinical Nutrition 80, 1353-1357.
91. Laugerette, F., Vors, C., Géloën, A., Chauvin, M.A., Soulage, C., Lambert-Porcheron, S., Peretti, N., et al. (2010) Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. Journal of Nutritional Biochemistry 22, 53-59.
92. Leaf, A. and Weber, P.C. (1988) Cardiovascular effects of n-3 fatty acids. New England Journal of Medicine 318, 549-557.
93. Lichtenstein, A.H., Brands, M., Franch, H.A., et al. (2006) Diet and lifestyle recommendations revision 2006.
94. Lin, R.Y., Choudhury, W., Cai, W., et al. (2003) Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 168, 213-220.
95. Liu, J., Zhao, S., Tang, J., et al. (2009) Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-kappaB. FEBS Journal 276, 4598-4606.
96. Logsdon, C.D., Fuentes, M.K., Huang, E.H. and Arumugam, T. (2007) RAGE and RAGE ligands in cancer. Current Molecular Medicine 7, 777-789.
97. Ma, L. and Nicholson, L.F. (2004) Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus. Brain Research 1018, 10-17.
98. Maillard, L.C. (1912) Action des acids amine sur des sucres: formation des melanoides per voie methodique. Comptes Rendus de l'Académie des Sciences 154, 66-68.
99. Malekinejad, H., Scherpenisse, P. and Bergwerff, A.A. (2006) Naturally occurring estrogens in processed milk and in raw milk (from gestated cows). Journal of Agricultural and Food Chemistry 54, 9785-9791.
100. Matsumoto, T., Tsurumoto, T., Baba, H., et al. (2007) Measurement of advanced glycation end products in skin of patients with rheumatoid arthritis, osteoarthritis, and dialysis-related spondyloarthropathy using non-invasive methods. Rheumatology International 28, 157-160.
101. Mattson, M.P. (2003) Will caloric restriction and folate protect against AD and PD? Neurology 60, 690-695.
102. McCarty, M.F. (2005) Secondary hyperparathyroidism promotes the acute phase response-a rationale for supplementing vitamin D in prevention of vascular events in elderly. Medical Hypotheses 64, 1022-1026.
103. McCarty, M.F., Barroso-Aranda, J. and Contreras, F. (2009) The low-methionine content of vegan diets may make methionine restriction feasible as a life extension strategy. Medical Hypotheses 72, 125-128.
104. Meerwaldt, R., Links, T., Graaff, R., et al. (2005a) Simple noninvasive measurement of skin autofluorescence. Annals of the Academy of Sciences 1043, 290-298.
105. Meerwaldt, R., Hartog, J.W., Graaff, R., et al. (2005b) Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. Journal of the American Society of Nephrology 16, 3687-3693.
106. Meerwaldt, R., Links, T., Zeebregts, C., et al. (2008) The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes. Cardiovascular Diabetology 7, 29.
107. Melo, A., Viegas, O., Petisca, C., et al. (2008) Effect of beer/red wine marinades on the formation of heterocyclic aromatic amines in pan-fried beef. Journal of Agricultural and Food Chemistry 56, 10625-10632.
108. Meyer, T.E., Kovacs, S.J., Ehsani, A.A., et al. (2006) Long-term caloric restriction ameliorates the decline in diastolic function in humans. Journal of the American College of Cardiology 47, 398-402.
109. Miyata, T., Kawai, R., Taketomi, S. and Sprague, S.M. (1996) Possible involvement of advanced glycation end-products in bone resorption. Nephrology Dialysis Transplantation 11, 54-57.
110. Mohr, S.B., Gorham, E.D., Garland, C.F., et al. (2006) Are low ultraviolet B and high animal protein intake associated with risk of renal cancer? International Journal of Cancer 119, 2705-2709.
111. Mohr, S.B., Garland, C.F., Gorham, E.D., et al. (2007) Is ultraviolet B irradiance inversely associated with incidence rates of endometrial cancer: an ecological study of 107 countries. Preventive Medicine 45, 327-331.
112. Mohr, S.B., Garland, C.F., Gorham, E.D. and Garland, F.C. (2008) The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 51, 1391-1398.
113. Monnier, V.M., Bautista, O., Kenny, D., et al. (1999) Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes control and complications trial. Diabetes 48, 870-880.
114. Monnier, V.M., Sell, D.R. and Genuth, S. (2005) Glycation products as markers and predictors of the progression of diabetic complications. Annals of the New York Academy of Sciences 1043, 567-581.
115. Moreira, P.I., Smith, M.A., Zhu, X., et al. (2005) Oxidative stress and neurodegeneration. Annals of the New York Academy of Sciences 1043, 543-552.
116. Moss, M. and Freed, D.L. (1999) Survival trends, coronary event rates, and the MONICA project. Monitoring trends and determinants in cardiovascular disease. Lancet 354, 862-865.
117. Mulder, D.J., Bieze, M., Graaff, R., et al. (2010) Skin autofluorescence is elevated in neovascular age-related macular degeneration. British Journal of Ophthalmology 94, 622-625.
118. Müller, M. and Lier, D. (1994) Fermentation of fructans by epiphytic lactic acid bacteria. Journal of Applied Bacteriology 76, 406-411.
119. Naaber, P., Smidt, I., Stsepetova, J., et al. (2004) Inhibition of Clostridium difficile strains by intestinal Lactobacillus species. Journal of Medical Microbiology 53, 551-554.
120. Nagaraj, R.H., Padmanabha, S., Mailanko, M., et al. (2010) Modulation of advanced glycation endproduct synthesis by kynurenines in human lens proteins. Biochimica et Biophysica Acta 1804, 829-838.
121. Nandhini, A.T.A., Thirunavakkarasu, V. and Anuradha, C.V. (2004) Stimulation of glucose utilization and inhibition of protein glycation and AGE products by taurine. Acta Physiologica Scandinavica 181, 297-303.
122. Nandhini, A.T.A., Thirunavakkarasu, V. and Anuradha, C.V. (2005) Taurine prevents collagen abnormalities in high fructose-fed rats. Indian Journal of Medical Research 122, 171-177.
123. Ni, J., Yuan, X., Gu, J., et al. (2009) Plasma protein pentosidine and carboxymethyllysine, biomarkers for age-related macular degeneration. Molecular & Cellular Proteomics 8, 1921-1933.
124. Nicolls, M.R. (2004) The clinical and biological relationship between type II diabetes mellitus and Alzheimer's disease. Current Alzheimer Research 1, 47-54.
125. Odetti, P., Angelini, G., Dapino, D., et al. (1998) Early glycoxidation damage in brains from Down's syndrome. Biochemical and Biophysical Research Communications 243, 849-851.
126. Odetti, P., Rossi, S., Monacelli, F., et al. (2005) Advanced glycation end products and bone loss during aging. Annals of the New York Academy of Sciences 1043, 710-717.
127. Orasanu, G. and Plutzky, J. (2009) The pathologic continuum of diabetic vascular disease. Journal of the American College of Cardiology 53, S35-42.
128. Osawa, T. and Kato, Y. (2005) Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Annals of the New York Academy of Sciences 1043, 440-451.
129. Ostergaard, J., Hansen, T.K., Thiel, S. and Flyvbjerg, A. (2005) Complement activation and diabetic vascular complications. Clinica Chimica Acta 361, 10-19.
130. Outwater, J.L., Nicholson, A. and Barnard, N. (1997) Dairy products and breast cancer: the IGF-I, estrogen, and bGH hypothesis. Medical Hypotheses 48, 453-461.
131. Papachroni, K.K., Piper, C., Levidou, G., Korkolopoulou, P., Pawelczyk, L., Diamanti-Kandarakis, E. and Papavassiliou, A.G. (2009) Lysyl oxidase interacts with AGEs signaling to modulate collagen synthesis in polycystic ovarian tissue. Journal of Cellular and Molecular Medicine 14, 2460-2469. doi: 10.1111/j.1582-4934.2009.00841.x.
132. Peppa, M., Brem, P., Ehrlich, J., et al. (2003) Adverse effects of glycotoxins on wound healing in genetically diabetic mice. Diabetes 52, 2805-2813.
133. Peskind, E.R., Elrod, R., Dobie, D.J., et al. (1998) Cerebrospinal fluid epinephrine in Alzheimer's disease and normal aging. Neuropsychopharmacology 19, 465-471.
134. Platz, E.A., Willett, W.C., Colditz, G.A., et al. (2000) Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control 11, 579-588.
135. Rahman, I., Biswas, S.K. and Kode, A. (2006a) Oxidant and antioxidant balance in the airways and airway diseases. European Journal of Pharmacology 533, 222-239.
136. Rahman, I., Biswas, S.K. and Kirkham, P.A. (2006b) Regulation of inflammation and redox signaling by dietary polyphenols. Biochemical Pharmacology 72, 1439-1452.
137. Ramamurthy, B., Hook, P., Jones, A.D. and Larsson, L. (2001) Changes in myosin structure and function in response to glycation. FASEB Journal 15, 2415-2422.
138. Rautava, S. and Isolauri, E. (2004) Cow's milk allergy in infants with atopic eczema is associated with aberrant production of interleukin-4 during oral cow's milk challenge. Journal of Pediatric Gastroenterology and Nutrition 39, 529-535.
139. Reddy, G.K. (2004) Cross-linking in collagen by nonenzymatic glycation increases the matrix stiffness in rabbit achilles tendon. Experimental Diabesity Research 5, 143-153.
140. Reeves, M.J. and Rafferty, A.P. (2005) Healthy lifestyle characteristics among adults in the United States 2000. Archives of Internal Medicine 165, 854-857.
141. Rehbein, G., Simm, A. and Hofmann, H.S. (2008) Molecular regulation of S100P in human lung adenocarcinomas. International Journal of Molecular Sciences 22, 69-77.
142. Rosca, M.G., Mustata, T.G., Kinter, M.T., et al. (2005) Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. American Journal of Physiology-Renal Physiology 289, F420-F430.
143. Rüster, M., Franke, S., Späth, M., et al. (2005) Detection of elevated N epsilon-carboxymethyllysine levels in muscular tissue and in serum of patients with fibromyalgia. Scandinavian Journal of Rheumatology 34, 460-463.
144. Sancho, A.I., Rigby, N.M., Zuidmeer, L., et al. (2005) The effect of thermal processing on the IgE reactivity of the non-specific lipid transfer protein from apple, Mal d 3. Allergy 60, 1262-1268.
145. Sasaki, N., Takeuschi, M., Choei, H., et al. (2002) Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jacob disease with prion plaques. Neuroscience Letters 326, 117-120.
146. Sbarbati, A., Valleta, E., Bertini, M., et al. (2003) Gluten sensitivity and 'normal' histology: is the intestinal mucosa really normal? Digestive and Liver Disease 35, 768-773.
147. Schepers, E., Glorieux, G. and Vanholder, R. (2010) The gut: the forgotten organ in uremia? Blood Purification 29, 130-136.
148. Schmidt, A.M., Vianna, M., Gerlach, M., et al. (1992) Isolation and characterization of binding proteins for advanced glycosylation endproducts from lung tissue which are present on the endothelial cell surface. Journal of Biological Chemistry 267, 14987-14997.
149. Schmidt, A.M., Yan, S.D., Brett, J., et al. (1993) Regulation of mononuclear phagocyte migration by cell surface binding proteins for advanced glycosylation endproducts. Journal of Clinical Investigation 92, 2155-2168.
150. Schmidt, A.M., Mora, R., Cao, R., et al. (1994a) The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide. Journal of Biological Chemistry 269, 9882-9888.
151. Schmidt, A.M., Hasu, M., Popov, D., et al. (1994b) The receptor for Advanced Glycation End products (AGEs) has a central role in vessel wall interactions and gene activation in response to AGEs in the intravascular space. Proceedings of the National Academy of Sciences USA 91, 8807-8811.
152. Schmidt, A.M., Yan, S.D., Yan, S.F. and Stem, D.M. (2001) The multiligand receptor RAGE is a progression factor amplifying immune and inflammatory responses. Journal of Clinical Investigation 108, 949-955.
153. Sebekova, K., Krajcoviova-Kudlackova, M., Schinzel, R., et al. (2001) Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet. European Journal of Nutrition 40, 275-281.
154. Sebekova, K., Kupcova, V., Schinzel, R. and Heidland, A. (2002) Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis-amelioration by liver transplantation. Journal of Hepatology 36, 66-71.
155. Semba R.D., Bandinelli, S., Sun, K., et al. (2009) Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults. Journal of the American Geriatric Society 57, 1874-1680.
156. Smith, M.A., Taneda, S., Rickey, P.L., et al. (1994) Advanced Maillard reaction end products are associated with Alzheimer pathology. Proceedings of the National Academy of Sciences USA 91, 5710-5714.
157. Soldatos, G., Cooper, M.E. and Jandeleit-Dahm, K.A. (2005) Advanced-glycation end products in insulinresistant states. Current Hypertension Reports 7, 96-102.
158. Stamatas, G.N., Estanislao, R.B., Suero, M., et al. (2006) Facial skin fluorescence as a marker of the skin's response to chronic environmental insults and its dependence on age. British Journal of Dermatology 154, 125-132.
159. Stampfer, M.J., Hu, F.B., Manson, J.E., et al. (2000) Primary prevention of coronary heart disease in women through diet and lifestyle. New England Journal of Medicine 343, 16-22.
160. Steenvoorden, M.M., Huizinga, T.W., Verzijl, N., et al. (2006) Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis & Rheumatism 54, 253-263.
161. Stitt, A.L. (2005) The Maillard reaction in eye disease. Annals of the New York Academy of Sciences 1043, 582-597.
162. Sun A.Y., Wang, Q., Simonyi, A. and Sun, G.Y. (2010) Resveratrol as a therapeutic agent for neurodegenerative diseases. Molecular Neurobiology 41, 375-83.
163. Sunahori, K., Yamamura, M., Yamana, J., et al. (2006) Increased expression of receptor for advanced glycation end products by synovial tissue macrophages in rheumatoid arthritis. Arthritis & Rheumatism 54, 97-104.
164. Suzuma, K., Otani, A., Oh, H., et al. (1999) 17- Beta-estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells. Investigative Ophthalmology & Visual Science 40, 2122-2129.
165. Takada, M., Hirata, K., Ajiki, T., Suzuki, Y. and Kuroda, Y. (2004) Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells. Hepatogastroenterology 51, 928-930.
166. Taki, K., Takayama, F., Tsuruta, Y. and Niwa, T. (2006) Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients. Kidney International 70, 218-224.
167. Tateno, T., Ueno, S. and Hiwatashi, K. (2008) Expression of receptor for advanced glycation end products (RAGE) is related to prognosis in patients with esophageal squamous cell carcinoma. Annals of Surgical Oncology 16, 440-446.
168. Tavan, E., Cayuela, C., Antoine, J.M. and Cassand, P. (2002) Antimutagenic activities of various lactic acid bacteria against food mutagens: heterocyclic amines. Journal of Dairy Research 69, 335-341.
169. Tezel, G., Luo, C. and Yang, X. (2007) Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Investigative Ophthalmology & Visual Science 48, 1201-1211.
170. Thiel, R. and Fowkes, S.W. (2005) Can cognitive deterioration associated with Down syndrome be reduced? Medical Hypotheses 64, 524-532.
171. Tikellis, C., Cooper, M.E. and Thomas, M.C. (2006) Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes. The International Journal Of Biochemistry & Cell Biology 38, 737-751.
172. Tikellis, C., Thomas, M.C., Harcourt, B.E., Coughlan, M.T., Pete, J., Bialkowski, K., Tan, A., et al. (2008) Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. American Journal of Physiology-Endocrinology and Metabolism 295, E323-330.
173. Tlaskalová-Hogenová, H., Tucková, L., Stepánková, R., et al (2005) Involvement of innate immunity in the development of inflammatory and autoimmune diseases. Annals of New York Academy of Science 1051, 787-798.
174. Tokita, Y., Hirayama, Y., Sekikawa, A., et al. (2005) Fructose ingestion enhances atherosclerosis and deposition of advanced glycated end-products in cholesterol-fed rabbits. Journal of Atherosclerosis and Thrombosis 12, 260-267.
175. Tsukahara, H., Shibata, R., Ohta N., et al. (2003) High levels of urinary pentosidine, an advanced glycation end product, in children with acute exacerbation of atopic dermatitis: relationship with oxidative stress. Metabolism 52, 1601-1605.
176. Tucker, K.L., Morita, K., Qiao, N., et al. (2006) Colas, but not other carbonated beverages, are associated with low bone mineral density in older women: The Framingham Osteoporosis Study. American Journal of Clinical Nutrition 84, 936-942.
177. Unno, Y., Sakai, M., Sakamoto, Y., et al. (2004) Advanced glycation end products-modified proteins and oxidized LDL mediate down-regulation of leptin in mouse adipocytes via CD36. Biochemical and Biophysical Research Communications 325, 151-156.
178. Uribarri, J. and Tuttle, K.R. (2006) Advanced glycation end products and nephrotoxicity of high-protein diets. Clinical Journal of the American Society of Nephrology 1, 1293-1299.
179. Uribarri, J., Woodruff, S., Goodman, S., et al. (2010). Advanced glycation end products in foods and a practical guide to their reduction in the diet. Journal of American Dietetic Association 110, 911-916.
180. US Department of Health and Human Services, National Institutes of Health, and National Heart, Lung, and Blood Institute (2006) Your Guide to Lowering Your Blood Pressure with Dietary Approach to Stop Hypertension (DASH).
181. NIH Publication 06-4082, revision of 1st ed. (1988).
182. Visentin, S., Medana, C., Barge, A., et al. (2010) Microwave-assisted Maillard reactions for the preparation of advanced glycation end products (AGEs). Organic & Biomolecular Chemistry 21, 2473-2477.
183. Vitek, M.P., Bhattacharya, K., Gendening, J.M., et al. (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proceedings of the National Academy of Sciences USA 91, 4766-4770.
184. Vlassara, H. (2005) Advanced glycation in health and disease. Role of the modern environment. Annals of the New York Academy of Sciences 1043, 452-460.
185. Vlassara, H., Cai, J., Crandall, J., et al. (2002) Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proceedings of the National Academy of Sciences USA 99, 15596-15601.
186. Vlassara, H., Torreggiani, M., Post, J.B., et al. (2009) Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging. Kidney International Supplement 14, S3-11.
187. Wiame, E., Delpierre, G., Collard, F. and Van Schaftingen, E. (2002) Identification of a pathway for the utilization of the Amadori product fructoselysine in Escherichia coli. Journal of Biological Chemistry 277, 42523-42529.
188. Yagmur, E., Tacke., F., Weiss, C.P., et al. (2006) Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis. Clinical Biochemistry 39, 39-45.
189. Yamagishi, S., Fujimori, H., Yonekura, H., et al. (1998) Advanced glycation end products inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologica 41, 1435-1441.
190. Yan, S.F., Ramasamy, R. and Schmidt, A.M. (2009) Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response. Journal of Molecular Medicine 87, 235-247.
191. Zeng, S., Feirt, N., Goldstein, M., et al. (2004) Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. Hepatology 39, 422-432.
192. Zheng, F., He, C., Cai, W., et al. (2002) Prevention of nephropathy in mice by a diet low in glycoxidation products. Diabetes/Metabolism Research and Reviews 18, 224-237.
193. Zimmerman, G.A., Meistrell, M., Bloom, O., et al. (1995) Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine. Proceedings of the National Academy of Sciences USA 92, 3744-3748.
194. Zittermann, A., Schleithoff, S.S. and Koerfer, R. (2005) Putting cardiovascular disease and vitamin D insufficiency into perspective. British Journal of Nutrition 94, 483-492.